PET/CT in the assessment of previously treated skull base malignancies

Head and Neck

Volumn 32, Issue 1, 2010, Pages 76-84

  Harvey, Richard J ^a,b   Pitzer, Geoff ^a   Nissman, Daniel B ^a   Buchmann, Luke ^c   Rumboldt, Zoran ^a   Day, Terry ^a   Schlosser, Rodney J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

PET; Positron; Recurrent; Skull base; Tumor

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; LARYNX TUMOR; MALE; MAXILLA TUMOR; MOUTH TUMOR; MUCOSA INFLAMMATION; NASOPHARYNX TUMOR; NEUROECTODERM TUMOR; OROPHARYNX TUMOR; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALIVARY GLAND TUMOR; SENSITIVITY AND SPECIFICITY; SKULL BASE TUMOR; SQUAMOUS CELL CARCINOMA;

AGED; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SKULL BASE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 75149146715     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21147     Document Type: Article

References (36)

1. Schelstraete K, Simons M, Deman J, et al. Uptake of 13N-ammonia by human tumours as studied by positron emission tomography. Br J Radiol 1982;55:797-804.
2. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Ho C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992;102:281-288.
3. Charron M, Beyer T, Bohnen NN, et al. Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin Nucl Med 2000;25:905-910.
4. Branstetter BF IV, Blodgett TM, Zimmer LA, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005;235:580-586.
5. Zimmer LA, Branstetter BF, Nayak JV, Johnson JT. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck. Laryngoscope 2005;115:2029-2034.
6. Greven KM. Positron-emission tomography for head and neck cancer. Semin Radiat Oncol 2004;14:121-129.
7. Hain SF. Positron emission tomography in cancer of the head and neck. Br J Oral Maxillofac Surg 2005;43:1-6.
8. Shintani SA, Foote RL, Lowe VJ, Brown PD, Garces YI, Kasperbauer JL. Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer. Int J Radiat Oncol Biol Phys 2008;70:322-329.
9. Hubner KF, Thie JA, Smith GT, Chan AC, Fernandez PS, McCoy JM. Clinical utility of FDG-PET in detecting head and neck tumors: a comparison of diagnostic methods and modalities. Clin Positron Imaging 2000;3:7-16.
10. Liu SH, Chang JT, Ng SH, Chan SC, Yen TC. False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient. Br J Radiol 2004;77:257-260.
11. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61-77; quiz 150-151.
12. Fischbein NJ, AAssar OS, Caputo GR, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 1998;19:1189-1196.
13. Yeung HW, Grewal RK, Gonen M, Schoder H, Larson SM. Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med 2003;44:1789-1796.
14. Evans KD, Tulloss TA, Hall N. 18FDG uptake in brown fat: potential for false positives. Radiol Technol 2007; 78:361-366.
15. Chadwick JL, Khalid A, Wagner H, Stack BC Jr. Teflon granuloma results in a false-positive "second primary" on 18F-2-deoxyglucose positron emission tomography in a patient with a history of nasopharyngeal cancer. Am J Otolaryngol 2007;28:251-253.
16. Aide N, Benayoun M, Kerrou K, Khalil A, Cadranel J, Talbot JN. Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy. Br J Radiol 2007; 80:e67-e71.
17. Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med 1995;36:1836-1839.
18. Wang G, Lau EW, Shakher R, et al. How do oncologists deal with incidental abnormalities on whole-body fluorine-18 fluorodeoxyglucose PET/CT? Cancer 2007;109:117-124.
19. Salaun PY, Abgral R, Querellou S, et al. Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up? Head Neck 2007;29:1115-1120.
20. Gil Z, Even-Sapir E, Margalit N, Fliss DM. Integrated PET/CT system for staging and surveillance of skull base tumors. Head Neck 2007;29:537-545.
21. Wong RJ, Lin DT, Schoder H, et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002;20:4199-4208.
22. Lapela M, Eigtved A, Jyrkkio S, et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 2000;36:858-867.
23. Cheon GJ, Chung JK, So Y, et al. Diagnostic accuracy of F-18 FDG-PET in the assessment of posttherapeutic recurrence of head and neck cancer. Clin Positron Imaging 1999;2:197-204.
24. Goshen E, Davidson T, Yahalom R, Talmi YP, Zwas ST. PET/CT in the evaluation of patients with squamous cell cancer of the head and neck. Int J Oral Maxillofac Surg 2006;35:332-336.
25. Kunkel M, Forster GJ, Reichert TE, et al. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management. Cancer 2003;98:2257-2265.
26. Lonneux M, Lawson G, Ide C, Bausart R, Remacle M, Pauwels S. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope 2000; 110:1493-1497.
27. Farber LA, Benard F, Machtay M, et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy- D-glucose positron emission tomography. Laryngoscope 1999;109: 970-975.
28. Kao CH, ChangLai SP, Chieng PU, Yen RF, Yen TC. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 1998;16:3550-3555.
29. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro- D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135-141.
30. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[FPET/18]fluoro-2-deoxy-D-glucose. Radiology 1995;197:205-211.
31. Lee JC, Kim JS, Lee JH, et al. F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma. Oral Oncol 2007;43: 686-692.
32. Zimmer LA, Snyderman C, Fukui MB, et al. The use of combined PET/CT for localizing recurrent head and neck cancer: the Pittsburgh experience. Ear Nose Throat J 2005;84:104.
33. Kitagawa Y, Nishizawa S, Sano K, et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 2003;44:198-206.
34. Hanasono MM, Kunda LD, Segall GM, Ku GH, Terris DJ. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999;109:880-885.
35. Stokkel MP, Terhaard CH, Hordijk GJ, van Rijk PP. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med 1999;26:767-773.
36. Lowe VJ, Hoffman JM, DeLong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35:1771-1776.